Skip to content

Can a high fibre diet reduce the amount of insulin the body needs to process the sugar consumed in meals?

Can supplemented dietary fibre improve insulin sensitivity in obese adolescents? A randomized cross-over trial of a high fibre isocaloric diet compared to an isocaloric diet alone in a secondary school community with a high incidence of obesity.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12609000888268
Enrollment
40
Registered
2009-10-12
Start date
2010-02-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The purpose of the study is to formally assess the impact of fibre alone on insulin sensitivity, and if this is achieved independently of weight loss. Fibre will be givenas a supplement, without altering other aspects of the diet. The hypothesis is that the properties of fibre can benefit insulin senstivity independently of weight loss, clarifying its role in dietary interventions for overweight, and normal weight insulin resistant people. We expect the effect to be greatest in the obese population.

Interventions

Participants will be randomized to recieve 6g per day psyllium or 6g/d potato starch placebo for 6 weeks on each intervention. Psyllium and placebo will be given as 6g/day as 12 x 500mg capsules, with participants instructed to consume these at once or in divided doses with a large glass of water. After 6 weeks participants will washout for 2 weeks before starting 6 weeks on the opposite intervention.

Sponsors

University of Auckland / Liggins Institute
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Crossover
Primary purpose
Treatment
Masking
Blinded (masking used)

Eligibility

Sex/Gender
Male
Age
15 Years to 16 Years
Healthy volunteers
Yes

Inclusion criteria

15 - 16 year old males from low socio-economic areas.

Exclusion criteria

Receiving medications that influence insulin sensitivity (SI) (incluing oral steroids and metformin). Genetic conditions, (Turner, Downs or Prader-Willi syndrome). Coeliac disease or other malabsorption disorders.

Outcome results

None listed

Source: ANZCTR · Data processed: Mar 25, 2026